APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Therapeutics

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Veterinary Therapeutics Industry Growth and Trends Forecast to 2032

Report ID 174046240120 December 2025111 pages

Choose your research edition.

Industry ResearchVeterinary Therapeutics Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Therapeutics Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Veterinary Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Therapeutics Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Therapeutics Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

According to APO Research, the global Veterinary Therapeutics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Veterinary Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Veterinary Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Veterinary Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Veterinary Therapeutics market include CAHIC, Zoetis, Ringpu Biology, Merck, Virbac, Vetoquinol, Phibro, Ouro Fino Saude and Orion, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Veterinary Therapeutics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Veterinary Therapeutics market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Veterinary Therapeutics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Veterinary Therapeutics.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Veterinary Therapeutics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Veterinary Therapeutics Market by Company

CAHIC

Zoetis

Ringpu Biology

Merck

Virbac

Vetoquinol

Phibro

Ouro Fino Saude

Orion

Norbrook

Nippon Zenyaku Kogyo

Huvepharma

Hipra

Farmavet-Pasteur

Elanco

Dechra

Ceva

Boehringer Ingelheim

Veterinary Therapeutics Segment by Type

Analgesics

Sedatives

Anti-Inflammatory

Parasiticides

Anti-Infectives

Others

Veterinary Therapeutics Segment by Application

Swine

Cattle

Poultry

Pets

Others

Veterinary Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Veterinary Therapeutics companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Veterinary Therapeutics Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Veterinary Therapeutics Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Veterinary Therapeutics Market Share by Region (2021-2026) Table 4. Global Veterinary Therapeutics Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Veterinary Therapeutics Market Share by Region (2027-2032) Table 6. Global Veterinary Therapeutics Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Veterinary Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Veterinary Therapeutics Market Size Share by Type (2021-2026) Table 9. Global Veterinary Therapeutics Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Veterinary Therapeutics Market Size Share Forecasted by Type (2027-2032) Table 11. North America Veterinary Therapeutics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Veterinary Therapeutics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Veterinary Therapeutics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Veterinary Therapeutics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Veterinary Therapeutics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Veterinary Therapeutics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Veterinary Therapeutics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Veterinary Therapeutics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Veterinary Therapeutics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Veterinary Therapeutics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Veterinary Therapeutics Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Veterinary Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Veterinary Therapeutics Market Size Share by Application (2021-2026) Table 24. Global Veterinary Therapeutics Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Veterinary Therapeutics Market Size Share Forecasted by Application (2027-2032) Table 26. North America Veterinary Therapeutics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Veterinary Therapeutics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Veterinary Therapeutics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Veterinary Therapeutics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Veterinary Therapeutics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Veterinary Therapeutics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Veterinary Therapeutics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Veterinary Therapeutics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Veterinary Therapeutics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Veterinary Therapeutics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Veterinary Therapeutics Industry Trends Table 37. Veterinary Therapeutics Industry Drivers Table 38. Veterinary Therapeutics Industry Opportunities and Challenges Table 39. Veterinary Therapeutics Industry Restraints Table 40. Global Veterinary Therapeutics Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Veterinary Therapeutics Revenue Market Share by Company (2021-2026) Table 42. Global Veterinary Therapeutics Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Veterinary Therapeutics Key Company Headquarters & Area Served Table 44. Global Veterinary Therapeutics Company, Product Type & Application Table 45. Global Veterinary Therapeutics Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Veterinary Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. CAHIC Company Information Table 49. CAHIC Business Overview Table 50. CAHIC Veterinary Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. CAHIC Veterinary Therapeutics Product Portfolio Table 52. CAHIC Recent Development Table 53. Zoetis Company Information Table 54. Zoetis Business Overview Table 55. Zoetis Veterinary Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Zoetis Veterinary Therapeutics Product Portfolio Table 57. Zoetis Recent Development Table 58. Ringpu Biology Company Information Table 59. Ringpu Biology Business Overview Table 60. Ringpu Biology Veterinary Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Ringpu Biology Veterinary Therapeutics Product Portfolio Table 62. Ringpu Biology Recent Development Table 63. Merck Company Information Table 64. Merck Business Overview Table 65. Merck Veterinary Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Merck Veterinary Therapeutics Product Portfolio Table 67. Merck Recent Development Table 68. Virbac Company Information Table 69. Virbac Business Overview Table 70. Virbac Veterinary Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Virbac Veterinary Therapeutics Product Portfolio Table 72. Virbac Recent Development Table 73. Vetoquinol Company Information Table 74. Vetoquinol Business Overview Table 75. Vetoquinol Veterinary Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Vetoquinol Veterinary Therapeutics Product Portfolio Table 77. Vetoquinol Recent Development Table 78. Phibro Company Information Table 79. Phibro Business Overview Table 80. Phibro Veterinary Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Phibro Veterinary Therapeutics Product Portfolio Table 82. Phibro Recent Development Table 83. Ouro Fino Saude Company Information Table 84. Ouro Fino Saude Business Overview Table 85. Ouro Fino Saude Veterinary Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Ouro Fino Saude Veterinary Therapeutics Product Portfolio Table 87. Ouro Fino Saude Recent Development Table 88. Orion Company Information Table 89. Orion Business Overview Table 90. Orion Veterinary Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Orion Veterinary Therapeutics Product Portfolio Table 92. Orion Recent Development Table 93. Norbrook Company Information Table 94. Norbrook Business Overview Table 95. Norbrook Veterinary Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Norbrook Veterinary Therapeutics Product Portfolio Table 97. Norbrook Recent Development Table 98. Nippon Zenyaku Kogyo Company Information Table 99. Nippon Zenyaku Kogyo Business Overview Table 100. Nippon Zenyaku Kogyo Veterinary Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Nippon Zenyaku Kogyo Veterinary Therapeutics Product Portfolio Table 102. Nippon Zenyaku Kogyo Recent Development Table 103. Huvepharma Company Information Table 104. Huvepharma Business Overview Table 105. Huvepharma Veterinary Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Huvepharma Veterinary Therapeutics Product Portfolio Table 107. Huvepharma Recent Development Table 108. Hipra Company Information Table 109. Hipra Business Overview Table 110. Hipra Veterinary Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Hipra Veterinary Therapeutics Product Portfolio Table 112. Hipra Recent Development Table 113. Farmavet-Pasteur Company Information Table 114. Farmavet-Pasteur Business Overview Table 115. Farmavet-Pasteur Veterinary Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Farmavet-Pasteur Veterinary Therapeutics Product Portfolio Table 117. Farmavet-Pasteur Recent Development Table 118. Elanco Company Information Table 119. Elanco Business Overview Table 120. Elanco Veterinary Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Elanco Veterinary Therapeutics Product Portfolio Table 122. Elanco Recent Development Table 123. Dechra Company Information Table 124. Dechra Business Overview Table 125. Dechra Veterinary Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Dechra Veterinary Therapeutics Product Portfolio Table 127. Dechra Recent Development Table 128. Ceva Company Information Table 129. Ceva Business Overview Table 130. Ceva Veterinary Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Ceva Veterinary Therapeutics Product Portfolio Table 132. Ceva Recent Development Table 133. Boehringer Ingelheim Company Information Table 134. Boehringer Ingelheim Business Overview Table 135. Boehringer Ingelheim Veterinary Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Boehringer Ingelheim Veterinary Therapeutics Product Portfolio Table 137. Boehringer Ingelheim Recent Development Table 138. North America Veterinary Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Veterinary Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Veterinary Therapeutics Market Share by Country (2021-2026) Table 141. North America Veterinary Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Veterinary Therapeutics Market Share Forecast by Country (2027-2032) Table 143. Europe Veterinary Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Veterinary Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Veterinary Therapeutics Market Share by Country (2021-2026) Table 146. Europe Veterinary Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Veterinary Therapeutics Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Veterinary Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Veterinary Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Veterinary Therapeutics Market Share by Country (2021-2026) Table 151. Asia-Pacific Veterinary Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Veterinary Therapeutics Market Share Forecast by Country (2027-2032) Table 153. Latin America Veterinary Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Veterinary Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Veterinary Therapeutics Market Share by Country (2021-2026) Table 156. Latin America Veterinary Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Veterinary Therapeutics Market Share Forecast by Country (2027-2032) Table 158. Middle East & Africa Veterinary Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East & Africa Veterinary Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East & Africa Veterinary Therapeutics Market Share by Country (2021-2026) Table 161. Middle East & Africa Veterinary Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East & Africa Veterinary Therapeutics Market Share Forecast by Country (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Veterinary Therapeutics Product Image Figure 3. Global Veterinary Therapeutics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Veterinary Therapeutics Market Size (2021-2032) & (US$ Million) Figure 5. Global Veterinary Therapeutics Market Share by Region: 2025 VS 2032 Figure 6. Global Veterinary Therapeutics Market Share by Region (2021-2032) Figure 7. North America Veterinary Therapeutics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Veterinary Therapeutics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Veterinary Therapeutics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Veterinary Therapeutics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Veterinary Therapeutics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Analgesics Image Figure 13. Global Analgesics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Sedatives Image Figure 15. Global Sedatives Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Anti-Inflammatory Image Figure 17. Global Anti-Inflammatory Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Parasiticides Image Figure 19. Global Parasiticides Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Anti-Infectives Image Figure 21. Global Anti-Infectives Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Others Image Figure 23. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Global Veterinary Therapeutics Market Size Overview by Type (2021-2032) & (US$ Million) Figure 25. Global Veterinary Therapeutics Market Share by Type 2025 VS 2032 Figure 26. North America Veterinary Therapeutics Market Size Share by Type (2021-2032) Figure 27. Europe Veterinary Therapeutics Market Size Share by Type (2021-2032) Figure 28. Asia-Pacific Veterinary Therapeutics Market Size Share by Type (2021-2032) Figure 29. Latin America Veterinary Therapeutics Market Size Share by Type (2021-2032) Figure 30. Middle East and Africa Veterinary Therapeutics Market Size Share by Type (2021-2032) Figure 31. Swine Image Figure 32. Global Swine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Cattle Image Figure 34. Global Cattle Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Poultry Image Figure 36. Global Poultry Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Pets Image Figure 38. Global Pets Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Others Image Figure 40. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Global Veterinary Therapeutics Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global Veterinary Therapeutics Market Share by Application 2025 VS 2032 Figure 43. North America Veterinary Therapeutics Market Size Share by Application (2021-2032) Figure 44. Europe Veterinary Therapeutics Market Size Share by Application (2021-2032) Figure 45. Asia-Pacific Veterinary Therapeutics Market Size Share by Application (2021-2032) Figure 46. Latin America Veterinary Therapeutics Market Size Share by Application (2021-2032) Figure 47. Middle East and Africa Veterinary Therapeutics Market Size Share by Application (2021-2032) Figure 48. Global Top 5 and 10 Veterinary Therapeutics Players Market Share by Revenue in 2025 Figure 49. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 50. North America Veterinary Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. North America Veterinary Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. North America Veterinary Therapeutics Market Share by Country (2021-2032) Figure 53. Europe Veterinary Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Veterinary Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Veterinary Therapeutics Market Share by Country (2021-2032) Figure 56. Asia-Pacific Veterinary Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Asia-Pacific Veterinary Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Asia-Pacific Veterinary Therapeutics Market Share by Country (2021-2032) Figure 59. Latin America Veterinary Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Veterinary Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Veterinary Therapeutics Market Share by Country (2021-2032) Figure 62. Middle East & Africa Veterinary Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 63. Middle East & Africa Veterinary Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 64. Middle East & Africa Veterinary Therapeutics Market Share by Country (2021-2032) Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Analgesics
  • Sedatives
  • Anti-Inflammatory
  • Parasiticides
  • Anti-Infectives
  • Others
Applications
  • Swine
  • Cattle
  • Poultry
  • Pets
  • Others
Companies covered
  • CAHIC
  • Zoetis
  • Ringpu Biology
  • Merck
  • Virbac
  • Vetoquinol
  • Phibro
  • Ouro Fino Saude
  • Orion
  • Norbrook
  • Nippon Zenyaku Kogyo
  • Huvepharma
  • Hipra
  • Farmavet-Pasteur
  • Elanco
  • Dechra
  • Ceva
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Veterinary Therapeutics Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Veterinary Therapeutics Market Size by Region (2021-2032)
  5. 1.4.1 Global Veterinary Therapeutics Market Size by Region (2021-2026)
  6. 1.4.2 Global Veterinary Therapeutics Market Size by Region (2027-2032)
  7. 1.5 Key Regions Veterinary Therapeutics Market Size (2021-2032)
  8. 1.5.1 North America Veterinary Therapeutics Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Veterinary Therapeutics Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Veterinary Therapeutics Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Veterinary Therapeutics Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Veterinary Therapeutics Market Size Growth Rate (2021-2032)
2 Veterinary Therapeutics Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Analgesics
  3. 2.1.2 Sedatives
  4. 2.1.3 Anti-Inflammatory
  5. 2.1.4 Parasiticides
  6. 2.1.5 Anti-Infectives
  7. 2.1.6 Others
  8. 2.2 Global Veterinary Therapeutics Market Size by Type
  9. 2.2.1 Global Veterinary Therapeutics Market Size Overview by Type (2021-2032)
  10. 2.2.2 Global Veterinary Therapeutics Historic Market Size Review by Type (2021-2026)
  11. 2.2.3 Global Veterinary Therapeutics Market Size Forecasted by Type (2027-2032)
  12. 2.3 Global Veterinary Therapeutics Market Size by Regions
  13. 2.3.1 North America Veterinary Therapeutics Market Size Breakdown by Type (2021-2026)
  14. 2.3.2 Europe Veterinary Therapeutics Market Size Breakdown by Type (2021-2026)
  15. 2.3.3 Asia-Pacific Veterinary Therapeutics Market Size Breakdown by Type (2021-2026)
  16. 2.3.4 South America Veterinary Therapeutics Market Size Breakdown by Type (2021-2026)
  17. 2.3.5 Middle East and Africa Veterinary Therapeutics Market Size Breakdown by Type (2021-2026)
3 Veterinary Therapeutics Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Swine
  3. 3.1.2 Cattle
  4. 3.1.3 Poultry
  5. 3.1.4 Pets
  6. 3.1.5 Others
  7. 3.2 Global Veterinary Therapeutics Market Size by Application
  8. 3.2.1 Global Veterinary Therapeutics Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global Veterinary Therapeutics Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global Veterinary Therapeutics Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global Veterinary Therapeutics Market Size by Regions
  12. 3.3.1 North America Veterinary Therapeutics Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe Veterinary Therapeutics Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific Veterinary Therapeutics Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America Veterinary Therapeutics Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa Veterinary Therapeutics Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Veterinary Therapeutics Industry Trends
  2. 4.2 Veterinary Therapeutics Industry Drivers
  3. 4.3 Veterinary Therapeutics Industry Opportunities and Challenges
  4. 4.4 Veterinary Therapeutics Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Veterinary Therapeutics Revenue (2021-2026)
  2. 5.2 Global Veterinary Therapeutics Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Veterinary Therapeutics Key Company Headquarters & Area Served
  4. 5.4 Global Veterinary Therapeutics Company, Product Type & Application
  5. 5.5 Global Veterinary Therapeutics Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Veterinary Therapeutics Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Veterinary Therapeutics Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Veterinary Therapeutics Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 CAHIC
  2. 6.1.1 CAHIC Company Information
  3. 6.1.2 CAHIC Business Overview
  4. 6.1.3 CAHIC Veterinary Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 CAHIC Veterinary Therapeutics Product Portfolio
  6. 6.1.5 CAHIC Recent Developments
  7. 6.2 Zoetis
  8. 6.2.1 Zoetis Company Information
  9. 6.2.2 Zoetis Business Overview
  10. 6.2.3 Zoetis Veterinary Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Zoetis Veterinary Therapeutics Product Portfolio
  12. 6.2.5 Zoetis Recent Developments
  13. 6.3 Ringpu Biology
  14. 6.3.1 Ringpu Biology Company Information
  15. 6.3.2 Ringpu Biology Business Overview
  16. 6.3.3 Ringpu Biology Veterinary Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Ringpu Biology Veterinary Therapeutics Product Portfolio
  18. 6.3.5 Ringpu Biology Recent Developments
  19. 6.4 Merck
  20. 6.4.1 Merck Company Information
  21. 6.4.2 Merck Business Overview
  22. 6.4.3 Merck Veterinary Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Merck Veterinary Therapeutics Product Portfolio
  24. 6.4.5 Merck Recent Developments
  25. 6.5 Virbac
  26. 6.5.1 Virbac Company Information
  27. 6.5.2 Virbac Business Overview
  28. 6.5.3 Virbac Veterinary Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Virbac Veterinary Therapeutics Product Portfolio
  30. 6.5.5 Virbac Recent Developments
  31. 6.6 Vetoquinol
  32. 6.6.1 Vetoquinol Company Information
  33. 6.6.2 Vetoquinol Business Overview
  34. 6.6.3 Vetoquinol Veterinary Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Vetoquinol Veterinary Therapeutics Product Portfolio
  36. 6.6.5 Vetoquinol Recent Developments
  37. 6.7 Phibro
  38. 6.7.1 Phibro Company Information
  39. 6.7.2 Phibro Business Overview
  40. 6.7.3 Phibro Veterinary Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Phibro Veterinary Therapeutics Product Portfolio
  42. 6.7.5 Phibro Recent Developments
  43. 6.8 Ouro Fino Saude
  44. 6.8.1 Ouro Fino Saude Company Information
  45. 6.8.2 Ouro Fino Saude Business Overview
  46. 6.8.3 Ouro Fino Saude Veterinary Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Ouro Fino Saude Veterinary Therapeutics Product Portfolio
  48. 6.8.5 Ouro Fino Saude Recent Developments
  49. 6.9 Orion
  50. 6.9.1 Orion Company Information
  51. 6.9.2 Orion Business Overview
  52. 6.9.3 Orion Veterinary Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Orion Veterinary Therapeutics Product Portfolio
  54. 6.9.5 Orion Recent Developments
  55. 6.10 Norbrook
  56. 6.10.1 Norbrook Company Information
  57. 6.10.2 Norbrook Business Overview
  58. 6.10.3 Norbrook Veterinary Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Norbrook Veterinary Therapeutics Product Portfolio
  60. 6.10.5 Norbrook Recent Developments
  61. 6.11 Nippon Zenyaku Kogyo
  62. 6.11.1 Nippon Zenyaku Kogyo Company Information
  63. 6.11.2 Nippon Zenyaku Kogyo Business Overview
  64. 6.11.3 Nippon Zenyaku Kogyo Veterinary Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Nippon Zenyaku Kogyo Veterinary Therapeutics Product Portfolio
  66. 6.11.5 Nippon Zenyaku Kogyo Recent Developments
  67. 6.12 Huvepharma
  68. 6.12.1 Huvepharma Company Information
  69. 6.12.2 Huvepharma Business Overview
  70. 6.12.3 Huvepharma Veterinary Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Huvepharma Veterinary Therapeutics Product Portfolio
  72. 6.12.5 Huvepharma Recent Developments
  73. 6.13 Hipra
  74. 6.13.1 Hipra Company Information
  75. 6.13.2 Hipra Business Overview
  76. 6.13.3 Hipra Veterinary Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Hipra Veterinary Therapeutics Product Portfolio
  78. 6.13.5 Hipra Recent Developments
  79. 6.14 Farmavet-Pasteur
  80. 6.14.1 Farmavet-Pasteur Company Information
  81. 6.14.2 Farmavet-Pasteur Business Overview
  82. 6.14.3 Farmavet-Pasteur Veterinary Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Farmavet-Pasteur Veterinary Therapeutics Product Portfolio
  84. 6.14.5 Farmavet-Pasteur Recent Developments
  85. 6.15 Elanco
  86. 6.15.1 Elanco Company Information
  87. 6.15.2 Elanco Business Overview
  88. 6.15.3 Elanco Veterinary Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Elanco Veterinary Therapeutics Product Portfolio
  90. 6.15.5 Elanco Recent Developments
  91. 6.16 Dechra
  92. 6.16.1 Dechra Company Information
  93. 6.16.2 Dechra Business Overview
  94. 6.16.3 Dechra Veterinary Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Dechra Veterinary Therapeutics Product Portfolio
  96. 6.16.5 Dechra Recent Developments
  97. 6.17 Ceva
  98. 6.17.1 Ceva Company Information
  99. 6.17.2 Ceva Business Overview
  100. 6.17.3 Ceva Veterinary Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Ceva Veterinary Therapeutics Product Portfolio
  102. 6.17.5 Ceva Recent Developments
  103. 6.18 Boehringer Ingelheim
  104. 6.18.1 Boehringer Ingelheim Company Information
  105. 6.18.2 Boehringer Ingelheim Business Overview
  106. 6.18.3 Boehringer Ingelheim Veterinary Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Boehringer Ingelheim Veterinary Therapeutics Product Portfolio
  108. 6.18.5 Boehringer Ingelheim Recent Developments
7 North America
  1. 7.1 North America Veterinary Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Veterinary Therapeutics Market Size by Country (2021-2026)
  3. 7.3 North America Veterinary Therapeutics Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Veterinary Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Veterinary Therapeutics Market Size by Country (2021-2026)
  3. 8.3 Europe Veterinary Therapeutics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Veterinary Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Veterinary Therapeutics Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Veterinary Therapeutics Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Veterinary Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Veterinary Therapeutics Market Size by Country (2021-2026)
  3. 10.3 South America Veterinary Therapeutics Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Veterinary Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Veterinary Therapeutics Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Veterinary Therapeutics Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst